Guangshen Railway Co Ltd (601333.SS) stock: key figures, P/E, revenue and dividend
Industrials · Rail Transportation · China · ISIN CNE000001Q44
Guangshen Railway Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 27.09 bn CNY | 28.69 bn CNY |
| Gross profit | 1.70 bn CNY | 1.62 bn CNY |
| Operating income | 1.47 bn CNY | 1.53 bn CNY |
| EBIT | 1.47 bn CNY | 1.86 bn CNY |
| Net income | 1.06 bn CNY | 1.43 bn CNY |
| Diluted EPS – continuing operations | 0.15 CNY | 0.20 CNY |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Guangshen Railway Co Ltd
Guangshen Railway Company Limited engages in the railway passenger and freight transportation businesses in the People's Republic of China. Its passenger transportation services include the operation of Guangzhou-Shenzhen inter-city express trains, and long-distance trains. The company's freight transportation services comprise the transportation of full load cargos, containers, bulky and heavy cargo, dangerous goods, perishable goods, and oversized cargos. It also provides railway network usage; transportation; locomotive traction, railway lines, and power supply; passenger; and maintenance, loading, and unloading services, as well as sells food, beverages, and products on board the trains and in railway stations. In addition, the company is involved in train repairs, technical upgrades, sales of materials, goods and supplies, sewage collection services, on-board catering services, security and fire protection service, station and passenger service, leasing, and other businesses, as well as transportation equipment and facilities maintenance. The company was incorporated in 1996 and is based in Shenzhen, the People's Republic of China.
More stocks
- China National Medicines Corp Ltd (600511.SS)
- Suzhou Zelgen Biopharmaceuticals Co Ltd (688266.SS)
- PARK NATIONAL CORP /OH/ (PRK)
- Suzhou Everbright Photonics Co. Ltd. A (688048.SS)
- Avalon Advanced Materials Ltd (AVL.TO)
- Hill & Smith PLC (HILS.L)
- Optima Bank SA (OPTIMA.AT)
- Xinhu Zhongbao Co Ltd (600208.SS)
- Lepu Medical Tech Beijing (300003.SZ)
- Harbin Electric Co Ltd (1133.HK)
- Samsung Card Co. Ltd. (029780.KS)
- Mandatum Oyj (MANTA.HE)
Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.